Page 22 - அமைச்சகம் ஆஃப் அறிவியல் தொழில்நுட்பம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share Vaccine Discovery Programme supported by the Department of Biotechnology, Govt. of India under the Mission COVID Suraksha- The Indian COVID-19 Vaccine Development Mission, implemented by BIRAC, moves into clinical trials The Department of Biotechnology (DBT), Ministry of Science & Technologyhas announced that it has approved additional funding towards clinical studies of India’s’first of its kind’ mRNA-based COVID-19 vaccine – HGCO19, developed by Pune-based biotechnology company Gennova Biopharmaceuticals Ltd. This funding has been awarded under the’Mission COVID Suraksha- The Indian COVID-19 Vaccine Development Mission’by DBT’s dedicated Mission Implementation Unit at BiotechnologyIndustry Research Assistance Council (BIRAC) after multiplerounds of evaluation of all the applications that were submitted in response to the ‘Request for Expression of Interest (REOI)’under Mission COVID Surakshafor the’Development of COVID-19 vaccine candidate(s)’.

United statesSanjay singhRenu swarupBiotech corporationInterface agencyVaccine development missionGennova biopharmaceuticals ltdVaccine discovery programmeCentral drugs standard control organizationDepartment of biotechnologyCommittee on genetic manipulationBiotechnology industry research assistance councilVaccine development missionbyMinistry of science technologyhasMinistry of science technologyDevelopment mission